Argentina's state-run Nucleoelectrica has partnered with French nuclear group Framatome to conduct a pre-feasibility study on producing Lutetium-177, a vital medical isotope for cancer treatment, at its nuclear power plants. The study, which will take a year, aims to assess the technical and economic viability of the production process. This collaboration marks Argentina's initiative to expand its nuclear sector beyond electricity generation, enhancing its capabilities in isotope production, which already includes successful production of Cobalt-60 at the Embalse nuclear plant.
Tue, 26 Nov 2024 14:06:06 GMT | NucNet